Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Irradiation abolishes smooth muscle investment into vascular lesions in specific vascular beds
Alexandra A.C. Newman, … , Olga A. Cherepanova, Gary K. Owens
Alexandra A.C. Newman, … , Olga A. Cherepanova, Gary K. Owens
Published August 9, 2018
Citation Information: JCI Insight. 2018;3(15):e121017. https://doi.org/10.1172/jci.insight.121017.
View: Text | PDF
Research Article Vascular biology

Irradiation abolishes smooth muscle investment into vascular lesions in specific vascular beds

  • Text
  • PDF
Abstract

The long-term adverse effects of radiotherapy on cardiovascular disease are well documented. However, the underlying mechanisms responsible for this increased risk are poorly understood. Previous studies using rigorous smooth muscle cell (SMC) lineage tracing have shown abundant SMC investment into atherosclerotic lesions, where SMCs contribute to the formation of a protective fibrous cap. Studies herein tested whether radiation impairs protective adaptive SMC responses during vascular disease. To do this, we exposed SMC lineage tracing (Myh11-ERT2Cre YFP+) mice to lethal radiation (1,200 cGy) followed by bone marrow transplantation prior to atherosclerosis development or vessel injury. Surprisingly, following irradiation, we observed a complete loss of SMC investment in 100% of brachiocephalic artery (BCA), carotid artery, and aortic arch lesions. Importantly, this was associated with a decrease in multiple indices of atherosclerotic lesion stability within the BCA. Interestingly, we observed anatomic heterogeneity, as SMCs accumulated normally into lesions of the aortic root and abdominal aorta, suggesting that SMC sensitivity to lethal irradiation occurs in blood vessels of neural crest origin. Taken together, these results reveal an undefined and unintended variable in previous studies using lethal irradiation and may help explain why patients exposed to radiation have increased risk for cardiovascular disease.

Authors

Alexandra A.C. Newman, Richard A. Baylis, Daniel L. Hess, Steven D. Griffith, Laura S. Shankman, Olga A. Cherepanova, Gary K. Owens

×

Figure 1

Experimental design.

Options: View larger image (or click on image) Download as PowerPoint
Experimental design.
(A) Schematic of Myh11-CreERT2, ROSA26 STOP-flox eY...
(A) Schematic of Myh11-CreERT2, ROSA26 STOP-flox eYFP+/+ (SMC-YFP) mice. Upon tamoxifen injection, any cell transcribing Myh11 underwent excision of a floxed STOP codon in front of an eYFP transgene driven by the ROSA26 locus, allowing for permanent eYFP labeling of SMCs and their progeny. (B–D) SMC-YFP, Apoe–/– littermates at 9 weeks of age were subjected to 0 (nonirradiated, non-BMT controls) or 1,200 cGy of ionizing radiation and then administered >1 × 106 bone marrow cells (BMT). (B) Following 6 weeks of recovery to allow bone marrow engraftment, the mice were placed on a Western diet for 18 weeks to induce atherosclerosis formation. (C) Directly after radiation, mice were given a single BrdU pulse (10 mg/ml) and harvested at 1, 4, or 7 days after irradiation or 5 days after BrdU pulse for nonirradiated, non-BMT controls. (D) Following 6 weeks of recovery to allow bone marrow engraftment, mice underwent carotid ligation or femoral wire injury for 21 days. Bone marrow donor lines are indicated for each experiment. (E) Delineation of cut sites for vessels excised from the aortic outflow tract

Copyright © 2025 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts